Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 196

1.

Therapeutic Potential of Induced Neural Stem Cells for Parkinson's Disease.

Choi DH, Kim JH, Kim SM, Kang K, Han DW, Lee J.

Int J Mol Sci. 2017 Jan 22;18(1). pii: E224. doi: 10.3390/ijms18010224.

2.

Nanotechnology in the regulation of stem cell behavior.

Wu KC, Tseng CL, Wu CC, Kao FC, Tu YK, C So E, Wang YK.

Sci Technol Adv Mater. 2013 Oct 11;14(5):054401. eCollection 2013 Oct. Review.

3.

Grafted Neural Precursors Integrate Into Mouse Striatum, Differentiate and Promote Recovery of Function Through Release of Erythropoietin in MPTP-Treated Mice.

Carelli S, Giallongo T, Viaggi C, Gombalova Z, Latorre E, Mazza M, Vaglini F, Di Giulio AM, Gorio A.

ASN Neuro. 2016 Oct 27;8(5). pii: 1759091416676147. Print 2016 Oct.

4.

Development and Dynamic Regulation of Mitochondrial Network in Human Midbrain Dopaminergic Neurons Differentiated from iPSCs.

Fang D, Qing Y, Yan S, Chen D, Yan SS.

Stem Cell Reports. 2016 Oct 11;7(4):678-692. doi: 10.1016/j.stemcr.2016.08.014. Epub 2016 Sep 22.

5.
6.

Intrastriatal Grafting of Chromospheres: Survival and Functional Effects in the 6-OHDA Rat Model of Parkinson's Disease.

Boronat-García A, Palomero-Rivero M, Guerra-Crespo M, Millán-Aldaco D, Drucker-Colín R.

PLoS One. 2016 Aug 15;11(8):e0160854. doi: 10.1371/journal.pone.0160854. eCollection 2016.

7.

Effect of a feeder layer composed of mouse embryonic and human foreskin fibroblasts on the proliferation of human embryonic stem cells.

Yang H, Qiu Y, Zeng X, Ding Y, Zeng J, Lu K, Li D.

Exp Ther Med. 2016 Jun;11(6):2321-2328. Epub 2016 Mar 30.

8.

Gene Insertion Into Genomic Safe Harbors for Human Gene Therapy.

Papapetrou EP, Schambach A.

Mol Ther. 2016 Apr;24(4):678-84. doi: 10.1038/mt.2016.38. Epub 2016 Feb 12. Review.

9.

Maintenance of Viability and Function of Rat Islets With the Use of ROCK Inhibitor Y-27632.

Kubota Y, Noguchi H, Seita M, Yuasa T, Sasamoto H, Nakaji S, Okitsu T, Fujiwara T, Kobayashi N.

Cell Med. 2013 Oct 21;6(1-2):15-23. doi: 10.3727/215517913X674199. eCollection 2013 Dec 30.

10.

Merging DBS with viral vector or stem cell implantation: "hybrid" stereotactic surgery as an evolution in the surgical treatment of Parkinson's disease.

Rowland NC, Kalia SK, Kalia LV, Larson PS, Lim DA, Bankiewicz KS.

Mol Ther Methods Clin Dev. 2016 Jan 13;3:15051. doi: 10.1038/mtm.2015.51. eCollection 2016. Review.

11.

Mesenchymal Stem Cells of Dental Origin-Their Potential for Antiinflammatory and Regenerative Actions in Brain and Gut Damage.

Földes A, Kádár K, Kerémi B, Zsembery Á, Gyires K, S Zádori Z, Varga G.

Curr Neuropharmacol. 2016;14(8):914-934. Review.

PMID:
26791480
12.
13.

Stem cell transplantation therapy in Parkinson's disease.

Fu MH, Li CL, Lin HL, Chen PC, Calkins MJ, Chang YF, Cheng PH, Yang SH.

Springerplus. 2015 Oct 13;4:597. doi: 10.1186/s40064-015-1400-1. eCollection 2015. Review.

14.

Direct somatic lineage conversion.

Tanabe K, Haag D, Wernig M.

Philos Trans R Soc Lond B Biol Sci. 2015 Oct 19;370(1680):20140368. doi: 10.1098/rstb.2014.0368. Review.

15.

Magnetic Particle Imaging tracks the long-term fate of in vivo neural cell implants with high image contrast.

Zheng B, Vazin T, Goodwill PW, Conway A, Verma A, Saritas EU, Schaffer D, Conolly SM.

Sci Rep. 2015 Sep 11;5:14055. doi: 10.1038/srep14055.

16.

Effect of Superparamagnetic Iron Oxide Nanoparticles-Labeling on Mouse Embryonic Stem Cells.

Parsa H, Shamsasenjan K, Movassaghpour A, Akbarzadeh P, Amoghli Tabrizi B, Dehdilani N, Lotfinegad P, Soleimanloo F.

Cell J. 2015 Summer;17(2):221-30. Epub 2015 Jul 11.

17.

Intracarotid Infusion of Mesenchymal Stem Cells in an Animal Model of Parkinson's Disease, Focusing on Cell Distribution and Neuroprotective and Behavioral Effects.

Cerri S, Greco R, Levandis G, Ghezzi C, Mangione AS, Fuzzati-Armentero MT, Bonizzi A, Avanzini MA, Maccario R, Blandini F.

Stem Cells Transl Med. 2015 Sep;4(9):1073-85. doi: 10.5966/sctm.2015-0023. Epub 2015 Jul 21.

18.

Stem cell-based approach for the treatment of Parkinson's disease.

Goodarzi P, Aghayan HR, Larijani B, Soleimani M, Dehpour AR, Sahebjam M, Ghaderi F, Arjmand B.

Med J Islam Repub Iran. 2015 Jan 28;29:168. eCollection 2015. Review.

19.

Survival, differentiation, and neuroprotective mechanisms of human stem cells complexed with neurotrophin-3-releasing pharmacologically active microcarriers in an ex vivo model of Parkinson's disease.

Daviaud N, Garbayo E, Sindji L, Martínez-Serrano A, Schiller PC, Montero-Menei CN.

Stem Cells Transl Med. 2015 Jun;4(6):670-84. doi: 10.5966/sctm.2014-0139. Epub 2015 Apr 29.

20.

Using magnetic nanoparticles for gene transfer to neural stem cells: stem cell propagation method influences outcomes.

Pickard MR, Adams CF, Barraud P, Chari DM.

J Funct Biomater. 2015 Apr 24;6(2):259-76. doi: 10.3390/jfb6020259.

Supplemental Content

Support Center